Cellentia, Inc.

Overview

Cellentia is a specialized contract research organization (CRO) providing tailored bioassay and analytical services to support research and drug development. The company specializes in custom bioassay development, patient-derived organoid models, and immunological assays.

Core Service Lines

Custom Bioassay Services Cellentia designs and optimizes bioassays for drug screening and exploratory research applications.

Organoid Services Comprehensive organoid culturing services for both normal tissue and tumor samples. The company offers patient-derived 3D tumor organoid lines established from primary tumor tissue and circulating tumor cells, preserving genomic integrity and disease-specific phenotypes. These models are positioned as next-generation in vitro platforms for drug screening, translational oncology research, biomarker discovery, and precision medicine development.

Immunological & Analytical Assays

• AAV (Adeno-Associated Virus) assays
• Meso-Scale Discovery (MSD) assays for biomarker discovery and pharmacodynamic assessment
• ELISA assays
• Blood processing and PBMC isolation
• Mycoplasma detection via qPCR (detects 300+ species)

Differentiation

The company emphasizes patient-derived 3D tumor organoid models as scalable, predictive platforms that capture tumor complexity, heterogeneity, and clinically relevant treatment responses. Cellentia also maintains a portfolio of organoid lines available for purchase, enabling clients to access pre-established models for translational research.